Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 0.68%.

  • Harvard Bioscience's Return on Assets fell 5700.0% to 0.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68%, marking a year-over-year decrease of 5700.0%. This contributed to the annual value of 0.09% for FY2024, which is 700.0% down from last year.
  • Latest data reveals that Harvard Bioscience reported Return on Assets of 0.68% as of Q3 2025, which was down 5700.0% from 0.72% recorded in Q2 2025.
  • Harvard Bioscience's Return on Assets' 5-year high stood at 0.0% during Q4 2021, with a 5-year trough of 0.72% in Q2 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.04% (2022), whereas its average is 0.14%.
  • As far as peak fluctuations go, Harvard Bioscience's Return on Assets skyrocketed by 500bps in 2021, and later tumbled by -6400bps in 2025.
  • Harvard Bioscience's Return on Assets (Quarter) stood at 0.0% in 2021, then crashed by -1543bps to 0.07% in 2022, then surged by 64bps to 0.02% in 2023, then plummeted by -284bps to 0.1% in 2024, then tumbled by -612bps to 0.68% in 2025.
  • Its Return on Assets was 0.68% in Q3 2025, compared to 0.72% in Q2 2025 and 0.56% in Q1 2025.